arrakistx.comHealthcareFounded: 2015Funding to Date: $113.5MM
Arrakis Therapeutics is a biopharmaceutical company pioneering the discovery of a new class of medicines that directly target RNA.
For more details on financing and valuation for Arrakis Therapeutics, register or login.
View Enterprise Value for Arrakis Therapeutics.
To read this article and more news on Arrakis Therapeutics, register or login.